kristina [she/her]@hexbear.net to Science@hexbear.netEnglish · edit-25 months agoGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.www.cnbc.comexternal-linkmessage-square0fedilinkarrow-up11arrow-down10cross-posted to: news@lemmy.worldmedicine@mander.xyzlgbtq_plus@lemmy.blahaj.zonehealth@lemmy.worldnews@lemmy.world
arrow-up11arrow-down1external-linkGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.www.cnbc.comkristina [she/her]@hexbear.net to Science@hexbear.netEnglish · edit-25 months agomessage-square0fedilinkcross-posted to: news@lemmy.worldmedicine@mander.xyzlgbtq_plus@lemmy.blahaj.zonehealth@lemmy.worldnews@lemmy.world
